First, substantial heterogeneity was observed across the included studies, likely reflecting differences in study design, participant characteristics, GLP-1 receptor agonist types, follow-up duration, and methods used to assess depression outcomes
Plasminogen activator inhibitor-1 significantly decreased with liraglutide 3.0 mg versus placebo (Supplementary Table 8)
My Bottom Line GLP-1 medications have changed body composition for millions of people, often with genuinely significant health benefits, and the aesthetic skin changes that can accompany that weight loss are a real, increasingly well-documented consequence that extends well beyond the face
As reported, ROS generates hydrogen peroxide, which is a harmful molecule that can be scavenged by the glutathione peroxidase through GSH, it is found in the cytosol and the mitochondria, and by the catalase which is present in the peroxisomes
Forced swimming test in mice: a review of antidepressant activity
In prediabetes, metformin has evidence for delaying progression to type 2 diabetes in selected higher-risk groups, such as younger adults with higher body weight or people with a history of gestational diabetes
